Therapeutic and toxic effects observed with different dosage programs of cyclophosphamide in treatment of steroid-responsive but frequently relapsing nephrotic syndrome.
D000293:Adolescent; D000505:Alopecia / Q000139:chemically induced; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004064:Digestive System / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D008231:Lymphopenia / Q000139:chemically induced; D009404:Nephrotic Syndrome / Q000188:drug therapy*; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use*; D011507:Proteinuria / Q000188:drug therapy; D012008:Recurrence; D012075:Remission, Spontaneous; D014566:Urogenital System / Q000187:drug effects
D003520:Cyclophosphamide; D011239:Prednisolone